We also investigated IKZF1-COBL fusions in 25 newly diagnosed ALL samples with IKZF1 3′-end deletions (i.e. retention of IKZF1 exon 1 and a heterozygous deletion from exons 2, 3 or 4 through to exon 8). This evidence concerns the gene COBL and acute lymphoblastic leukemia.